Wordt geladen...
Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo
Epidermal growth factor receptor (EGFR) inhibitors have demonstrated efficacy in squamous cell carcinoma of the head and neck (SCCHN). In addition to EGFR, other ErbB family members are expressed and activated in SCCHN. Afatinib is an ErbB family blocker that has been approved for treating patients...
Bewaard in:
| Gepubliceerd in: | Target Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer International Publishing
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4492891/ https://ncbi.nlm.nih.gov/pubmed/25559287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-014-0353-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|